FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1963517571> ?p ?o ?g. }

• W1963517571 endingPage "235" @default.
• W1963517571 startingPage "229" @default.
• W1963517571 abstract "Options for relapsed/refractory indolent lymphoma include chemotherapy, immunotherapy and high-dose therapy with autologous support. The best combination of these approaches, however, is not defined. We treated 10 patients with relapsed/refractory follicular (n = 7) or mantle cell lymphoma (n = 3) using chemotherapy, immunotherapy, high-dose therapy and autotransplant in a sequence of four phases, each designed to play a specific role in tumour eradication. After the debulking with VACOP-B (doxorubicin, cyclophosphamide, etoposide, vincristine, prednisone, bleomycin) (phase 1), 9/10 patients responded but none achieved a molecular response. After the immuno-chemotherapy phase, which combined Rituximab with vincristine and cyclophosphamide, seven patients were in complete response (CR) and three in good partial response (PR), and all those with a molecular marker of disease showed a disappearance of the signal from marrow and blood. Phase 3, which coupled high-dose cytarabine with Rituximab, was effective in mobilizing an adequate number of progenitor cells that were polymerase chain reaction negative in all informative cases. Phase 4 consisted of high-dose therapy with autologous support followed by two doses of Rituximab. Autograft was performed in nine patients. The haematopoietic recovery was as expected. This sequence of chemotherapy, immuno-chemotherapy, stem cell mobilization with in vivo purging and autotransplant, organized in four blocks of treatment, was simple to administer and devoid of toxic effects. It permits rapid attainment of clinical and molecular response and enables the harvest of lymphoma-free peripheral blood progenitor cells even in heavily pretreated patients with relapsed or refractory disease." @default.
• W1963517571 created "2016-06-24" @default.
• W1963517571 creator A5011435773 @default.
• W1963517571 creator A5017814449 @default.
• W1963517571 creator A5019034145 @default.
• W1963517571 creator A5023971175 @default.
• W1963517571 creator A5025215179 @default.
• W1963517571 creator A5028336640 @default.
• W1963517571 creator A5029792149 @default.
• W1963517571 creator A5035302966 @default.
• W1963517571 creator A5044885843 @default.
• W1963517571 creator A5048978757 @default.
• W1963517571 creator A5060211572 @default.
• W1963517571 creator A5066134624 @default.
• W1963517571 creator A5070425079 @default.
• W1963517571 creator A5077129079 @default.
• W1963517571 creator A5081294616 @default.
• W1963517571 date "2002-01-01" @default.
• W1963517571 modified "2023-10-16" @default.
• W1963517571 title "A sequence of immuno-chemotherapy with Rituximab, mobilization of <i>in vivo</i> purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma" @default.
• W1963517571 cites W1486753210 @default.
• W1963517571 cites W1504115866 @default.
• W1963517571 cites W1912693401 @default.
• W1963517571 cites W1915689252 @default.
• W1963517571 cites W1921096083 @default.
• W1963517571 cites W196014493 @default.
• W1963517571 cites W1990066058 @default.
• W1963517571 cites W1990892742 @default.
• W1963517571 cites W2015470347 @default.
• W1963517571 cites W2168926834 @default.
• W1963517571 cites W2187116010 @default.
• W1963517571 cites W2249107533 @default.
• W1963517571 cites W2273653925 @default.
• W1963517571 cites W329934425 @default.
• W1963517571 doi "https://doi.org/10.1046/j.1365-2141.2002.03256.x" @default.
• W1963517571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11841421" @default.
• W1963517571 hasPublicationYear "2002" @default.
• W1963517571 type Work @default.
• W1963517571 sameAs 1963517571 @default.
• W1963517571 citedByCount "57" @default.
• W1963517571 countsByYear W19635175712012 @default.
• W1963517571 countsByYear W19635175712013 @default.
• W1963517571 countsByYear W19635175712014 @default.
• W1963517571 countsByYear W19635175712015 @default.
• W1963517571 crossrefType "journal-article" @default.
• W1963517571 hasAuthorship W1963517571A5011435773 @default.
• W1963517571 hasAuthorship W1963517571A5017814449 @default.
• W1963517571 hasAuthorship W1963517571A5019034145 @default.
• W1963517571 hasAuthorship W1963517571A5023971175 @default.
• W1963517571 hasAuthorship W1963517571A5025215179 @default.
• W1963517571 hasAuthorship W1963517571A5028336640 @default.
• W1963517571 hasAuthorship W1963517571A5029792149 @default.
• W1963517571 hasAuthorship W1963517571A5035302966 @default.
• W1963517571 hasAuthorship W1963517571A5044885843 @default.
• W1963517571 hasAuthorship W1963517571A5048978757 @default.
• W1963517571 hasAuthorship W1963517571A5060211572 @default.
• W1963517571 hasAuthorship W1963517571A5066134624 @default.
• W1963517571 hasAuthorship W1963517571A5070425079 @default.
• W1963517571 hasAuthorship W1963517571A5077129079 @default.
• W1963517571 hasAuthorship W1963517571A5081294616 @default.
• W1963517571 hasConcept C126322002 @default.
• W1963517571 hasConcept C143998085 @default.
• W1963517571 hasConcept C203014093 @default.
• W1963517571 hasConcept C2776694085 @default.
• W1963517571 hasConcept C2776755627 @default.
• W1963517571 hasConcept C2777058707 @default.
• W1963517571 hasConcept C2779338263 @default.
• W1963517571 hasConcept C2779429289 @default.
• W1963517571 hasConcept C2780653079 @default.
• W1963517571 hasConcept C71924100 @default.
• W1963517571 hasConceptScore W1963517571C126322002 @default.
• W1963517571 hasConceptScore W1963517571C143998085 @default.
• W1963517571 hasConceptScore W1963517571C203014093 @default.
• W1963517571 hasConceptScore W1963517571C2776694085 @default.
• W1963517571 hasConceptScore W1963517571C2776755627 @default.
• W1963517571 hasConceptScore W1963517571C2777058707 @default.
• W1963517571 hasConceptScore W1963517571C2779338263 @default.
• W1963517571 hasConceptScore W1963517571C2779429289 @default.
• W1963517571 hasConceptScore W1963517571C2780653079 @default.
• W1963517571 hasConceptScore W1963517571C71924100 @default.
• W1963517571 hasIssue "1" @default.
• W1963517571 hasLocation W19635175711 @default.
• W1963517571 hasLocation W19635175712 @default.
• W1963517571 hasOpenAccess W1963517571 @default.
• W1963517571 hasPrimaryLocation W19635175711 @default.
• W1963517571 hasRelatedWork W1937017173 @default.
• W1963517571 hasRelatedWork W1994176969 @default.
• W1963517571 hasRelatedWork W2028043880 @default.
• W1963517571 hasRelatedWork W2062566755 @default.
• W1963517571 hasRelatedWork W2083438316 @default.
• W1963517571 hasRelatedWork W2084396664 @default.
• W1963517571 hasRelatedWork W2094454764 @default.
• W1963517571 hasRelatedWork W2094591637 @default.
• W1963517571 hasRelatedWork W2418155614 @default.
• W1963517571 hasRelatedWork W2761932222 @default.
• W1963517571 hasVolume "116" @default.
• W1963517571 isParatext "false" @default.
• W1963517571 isRetracted "false" @default.

• next